Immune cell study for people with ankylosing spondylitis
Part of Bones, joints & muscles clinical trials.
This study looks at a specific white blood cell (called neutrophils) in people with ankylosing spondylitis. By measuring a marker called Tim-3 on these cells, researchers hope to learn more about the disease, which could help improve future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older
- You must have a diagnosis of ankylosing spondylitis (AS) as confirmed by your doctor
- You should not have any other autoimmune diseases
- You should not have any signs of infection at the time of the study
- You should not have metal implants or a pacemaker, or be pregnant
- You should not have uncontrolled high blood pressure, kidney failure, liver disease, cancer, or diabetes
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking for people with ankylosing spondylitis, rheumatoid arthritis, or lupus to help find biomarkers that may make diagnosis easier. If you have one of these conditions and haven't tried biologic therapies, you may be able to join.
This study looks at treatments for people with ankylosing spondylitis, a type of arthritis that affects the spine. It aims to find better ways to manage symptoms and improve quality of life.
This study tests a new treatment using umbilical cord stem cells given by injection to help reduce inflammation and improve symptoms of ankylosing spondylitis. It is for people who have not gotten enough relief from standard medications, including biologics.
This study looks at a protein called interleukin-33 in people with ankylosing spondylitis (a type of arthritis affecting the spine) and whether it is linked to early signs of heart disease. It aims to find out if this protein could help predict heart problems in people with this condition.
This study looks at the bacteria living in your body (the microbiome) in people with ankylosing spondylitis and their close family members. Researchers hope to better understand how these bacteria relate to the disease, which may lead to better treatments in the future.
This trial tests whether a single infusion of stem cells from a healthy donor's bone marrow can help reduce inflammation and pain in people with active ankylosing spondylitis. If you are young and have not been helped by standard treatments, this study might offer a new option.
Hear when a new Ankylosing Spondylitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.